Searched for
HIMADRI SPECIALTY CHEMICAL SHARE PRICE
Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
Avoid expensive themes, focus on valuations and stock picking: Samit VartakIndian equities have rebounded significantly, yet investor sentiment remains cautious due to ongoing geopolitical uncertainties. Despite th...
Top Nifty50 stocks analysts suggest buying in this volatile weekStock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...
Astral shares drop 6% after demerger. What should investors do?Astral shares fell nearly 6% on Monday after the company’s board approved the demerger of its chemicals business into a newly incorporated ...
World MSME Day: Chemical industry seeks policy support to boost competitiveness amid global trade disruptionsIndian chemical industry leaders are urging a policy overhaul to boost competitiveness ahead of World MSME Day 2026. They highlight the nee...
India Inc profit hit from West Asia tensions to halve if truce holds, Crisil saysCorporate India's profitability impact from the West Asia conflict is now expected to be half of initial fears, with Crisil Ratings predict...
Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...
Strong balance sheets help India Inc absorb West Asia fallout: CrisilA stress test by Crisil Ratings covering 34 sectors that account for 65% of its rated corporate debt suggests that India Inc remains broadl...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIt is probably time to be bullish as an investor. But remember two things. One: Valuations are still not cheap. Two: Because it is over and...
Tata Chemicals shares rise 4% on hopes of Tata Sons listing after RBI’s new normsTata Sons faces renewed scrutiny after RBI tightened rules for upper-layer NBFCs, reinforcing pressure for mandatory listings above Rs 1 la...
Capex boom, global sourcing tailwinds fuel textile stock rallyTextile exporter stocks witnessed a significant rally on Wednesday, boosted by positive initiation of coverage from Motilal Oswal Financial...
India's GIC Re plans to reduce share of overseas property risk as climate losses riseIndian reinsurer GIC Re is strategically shifting its overseas business focus. Amidst escalating climate-related losses globally, the compa...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 24%When business updates start to come in or when some FMCG or auto companies indicate that things are not all good in the rural space, we may...
Ahead of Market: 10 things that will decide stock market action on TuesdayIndian markets ended higher on Monday, snapping Friday's pause in momentum. Investors will track US-Iran developments, technical levels, se...
For long-term investors: Boring portfolio that wins difficult years; 5 large-cap stocks with upside potential up to 20%A sector leader is not just the company with the largest market share. Market share matters, but it is a result, not a cause. The cause is ...
Reliance to turn crude into carbon fibre, green chemicals, other materials in major O2C overhaulReliance Industries is set to reinvent its oil-to-chemicals business. The company will convert crude oil into advanced materials and green ...
These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...
Novyte, Chemvera partner to create pathway for AI-driven material discoveryThis collaboration leverages Novyte's AI engine for materials discovery and Chemvera's manufacturing expertise, creating an end-to-end Indi...
Sudip Bandyopadhyay bets on pharma, metals and select cyclicals as geopolitical risks easeEasing West Asia tensions boost global markets, prompting investors to reassess opportunities. Market veteran Sudip Bandyopadhyay favors ph...
Market Trading Guide: Akums Drugs among 4 stock recommendations for ThursdayDomestic equities ended lower amid global uncertainty and caution ahead of key US inflation data. Despite market weakness, analysts remain ...